AzTrials
AzTrials

Rheumatic DiseaseNCT05465356

Patient Engagement With Digital Health Tools in Rheumatology

An observational study of Rheumatic Disease and PROM, run by Guy's and St Thomas' NHS Foundation Trust.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to evaluate the patient engagement with digital tools for diagnosis and monitoring of disease in rheumatology services Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Rheumatic Disease, PROM
What is being tested?
Questionnaire and Semi-structured interview
How many people
3,000 participants
Where
No sites listed yet
Study dates
Jul 2022to Jul 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: All new patients referred to rheumatology outpatients + patients with inflammatory arthritis under follow up in rheumatology outpatients

Who may be able to join

  • Aged 18 years and above
  • Able to complete the questionnaire in English
  • 1. New patient pre-appointment questionnaires
  • Referred as a new patient to the rheumatology outpatient department at Guys and St Thomas' Trust between 01/01/2019 to 01/10/2023 and sent a digital pre-appointment questionnaire
  • Electronic patient notes recorded between 01/01/2019 to 01/10/2024
  • 2. Follow up patients PROM questionnaires
Show all 15Show fewer
  • Patients under followup of the rheumatology department at Guys and St Thomas' Trust with a diagnosis of rheumatoid arthritis, psoriatic arthritis or axial spondyloarthropathy who have been added to the remote monitoring program between 01/01/2019 to 01/10/2023
  • Electronic patient notes recorded between 01/01/2019 to 01/10/2024
  • Aged 18 years and above
  • 1. New patient pre-appointment questionnaires
  • Referred as a new patient to the rheumatology outpatient department at Guys and St Thomas' Trust between 01/01/2019 to 01/10/2023 and sent a digital pre-appointment questionnaire
  • Able to communicate in English or any language offered for audio interpreting by the LanguageLine service
  • 2. Follow up patients PROM questionnaires
  • Patients under followup of the rheumatology department at Guys and St Thomas' Trust with a diagnosis of rheumatoid arthritis, psoriatic arthritis or axial spondyloarthropathy who have been added to the remote monitoring program between 01/01/2019 to 01/10/2023
  • Able to communicate in English or any language offered for audio interpreting by the LanguageLine service

Who cannot join

  • Under 18 years of age
  • Unable to complete study questionnaires
  • Under 18 years of age
  • Patients lacking the capacity to consent for themselves for the semi-structured interview

Trial locations and contacts

No sites are listed yet.

Nikita Arumalla, MBBS, BSc contact

07834958748

nikita.arumalla@gstt.nhs.uk

About this study

The purpose of this study is to evaluate the patient engagement with digital tools for diagnosis and monitoring of disease in rheumatology services

Read the detailed description

The investigators plan to undertake a mixed methods study to investigate a digital algorithm to potentially inform triage of new patient referral to rheumatology services, as well as to inform follow up review schedules. Current practice at out hospital is to ask all newly referred patients to complete a pre-appointment digital questionnaire prior to their clinic visit. Patients who need follow up are then routinely invited to continue to return interval questionnaires related to their symptoms between clinic visits.

The investigators believe that the questionnaire responses could enable appropriate (and safe) allocation to a particular clinic (e.g. urgent early arthritis clinic or general rheumatology clinic for a new referral), or define an appropriate clinic follow up interval for a repeat visit for patients with a rheumatic disease.

Our study aims to evaluate these questionnaires using data collected from routine clinical practice, as well a series of semi-structured interviews with service users.

Being tested
Questionnaire, Semi-structured interview
Keywords
digital tools
Medical subject headings
Rheumatic Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • QuestionnaireOther

    Questionnaires completed as part of routine care - this is an observational study

  • Semi-structured interviewOther

    Semi-structured interview to review factors involved in patients engaging or not-engaging with the digital tools

Study groups in NCT05465356
Study groupRoleWhat they receive
New patientsAll new referrals seen in the rheumatology outpatients department, completing pre-appointment digital questionnaires
Receives: Other: Questionnaire; Other: Semi-structured interview
Follow-up patientsPatient with inflammatory arthritis completing ePROMs [electronic Patient Reported Outcome Measures] through the remote monitoring platform
Receives: Other: Questionnaire; Other: Semi-structured interview

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of patients with a non-inflammatory diagnosis

    Clinician assessed diagnosis as categorised into inflammatory [e.g. rheumatoid arthritis] or non-inflammatory [e.g osteoarthritis or fibromyalgia]

    Measured: 3 years

  2. Clinician assessed DAS-28 score for patients with rheumatoid arthritis

    Clinician assessment of disease activity at next follow-up visit for remote monitoring questionnaires

    Measured: 3 years

  3. Clinician assessed PsARC score for patients with psoriatic arthritis

    Clinician assessment of disease activity at next follow-up visit for remote monitoring questionnaires

    Measured: 3 years

  4. Rate of response to digital questionnaires

    Proportion of patients completing the new patient pre-appointment and follow-up remote monitoring questionnaires.

    Measured: 3 years

Secondary outcomes (2)
  1. PHQ8 scores in new patients completing pre-appointment questionnaires

    To estimate the prevalence of depression in new referrals to the rheumatology service. Score range 0 to 24, with higher score indicating more severe depression

    Measured: 3 years

  2. GAD7 scores in new patients completing pre-appointment questionnaires

    To estimate the prevalence of anxiety in new referrals to the rheumatology service. Score range 0 to 21, with higher score indicating more severe anxiety

    Measured: 3 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Jul 2022
  2. Study startJul 2022 (estimated)
  3. Primary completionOct 2024 (estimated)
  4. Study completionJul 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
3,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05465356
Sponsor's protocol ID
EDGE 147423
Status last verified
Jul 2022
First submitted
22 Jun 2022
Last updated
19 Jul 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Rheumatic Disease and PROM, run by Guy's and St Thomas' NHS Foundation Trust.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 15 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Nikita Arumalla, MBBS, BSc (07834958748, nikita.arumalla@gstt.nhs.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of patients with a non-inflammatory diagnosis (time frame: 3 years). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Jul 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in